Xilio Therapeutics, Inc. (XLO) Social Stream



Xilio Therapeutics, Inc. (XLO): $2.86

-0.16 (-5.30%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add XLO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#247 of 387

in industry

XILIO THERAPEUTICS INC (XLO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering XILIO THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-12 5 $40 $31 $34.75 $2.98 1066.11%
2022-08-09 4 $40 $31 $34.333 $2.98 1052.11%
2022-08-10 4 $40 $20 $30.333 $2.98 917.89%
2022-11-10 4 $20 $13 $16.5 $2.98 453.69%
2022-12-21 4 $20 $7 $13.333 $2.98 347.42%
2023-05-10 4 $13 $7 $10 $2.98 235.57%
NA 3 $NA $NA $NA $2.98 NA%

The Trend in the Analyst Price Target


XLO's average price target has moved down $0 over the prior 103 days.

XLO reports an average of 584.68% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-10 4 40 20 30.333 2.47 1128.06%
2022-11-10 4 20 13 16.500 2.44 576.23%
2022-11-10 3 40 13 24.333 2.44 897.25%
2022-11-10 4 40 13 24.333 2.44 897.25%
2023-05-10 4 13 7 10.000 3.20 212.5%

XLO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 1 0 0 0 4

The Trend in the Broker Recommendations


XLO's average broker recommendation rating improved by 0.15 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XLO as an investment opportunity.

  • XILIO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 750.33% of all US stocks.
  • In the context of all US stocks, XILIO THERAPEUTICS INC's number of analysts covering the stock is higher than 130.59% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, XILIO THERAPEUTICS INC's variance in analysts' estimates is lower than -215.2% of them.
  • XLO has a higher average analyst price target than 445.12% of stocks in the small market cap category.

Stocks similar to XILIO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LIAN, BWV, and ANTX.

Is XLO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7027 seconds.